A paper by examines payer perceptions of 5 totally different worth frameworks. Worth frameworks of curiosity included:

• American Society of Scientific Oncology (ASCO) Worth Framework,
• Drug Pricing Lab’s Drug Abacus (previously Memorial Sloan Kettering Most cancers Middle’s Drug Abacus),
• Institute for Scientific and Financial Assessment (ICER) worth evaluation framework and proof stories
• The Innovation and Worth Initiative (IVI)’s Open-Supply Worth Undertaking fashions,
• Nationwide Complete Most cancers Community (NCCN)’s Proof Blocks

The authors carried out a double-blind, web-based survey to evaluate payers’ perceptions of those worth frameworks. General, 51 well being care payer respondents discovered that the an important elements when deciding on a price framework was that (i) acceptable metrics and outcomes have been included, (ii) comparative scientific effectiveness info was supplied and (iii) the outcomes have been methodologically rigorous and unbiased.

Among the many 5 worth frameworks, ICER, NCCN and ASCO have been the worth frameworks thought-about most helpful for formulary selections, whereas ICER was far and away probably the most helpful for drug worth negotiations.